What are the diagnostic criteria for allergic bronchopulmonary aspergillosis (ABPA) in a patient with asthma or cystic fibrosis?

Diagnosis of ABPA

To diagnose ABPA, you must demonstrate two essential components—A. fumigatus-specific IgE ≥0.35 kUA·L⁻¹ AND serum total IgE ≥500 IU·mL⁻¹—plus any two of the following: positive A. fumigatus-specific IgG, blood eosinophil count ≥500 cells·μL⁻¹, or characteristic imaging findings (bronchiectasis, mucus plugging, high-attenuation mucus, or fleeting opacities). 1

Clinical Context

Suspect ABPA in patients with:

• Predisposing conditions: asthma, cystic fibrosis, COPD, or bronchiectasis
• Compatible clinical presentation: expectoration of brownish mucus plugs, recurrent wheezing despite treatment, episodic fever, hemoptysis, or lung collapse 1

Importantly, ABPA can occur even without a prior asthma diagnosis, though this is less common and may lead to diagnostic delays 2, 3.

Diagnostic Algorithm

Step 1: Initial Screening

In patients with predisposing conditions or compatible symptoms:

• Measure A. fumigatus-specific IgE first 1
• If ≥0.35 kUA·L⁻¹, proceed to Step 2
• If <0.35 kUA·L⁻¹, consider ABPM (allergic bronchopulmonary mycosis from non-Aspergillus fungi) 1

Step 2: Confirm Immunological Activity

• Measure serum total IgE 1
• If ≥500 IU·mL⁻¹, proceed to Step 3
• If <500 IU·mL⁻¹, diagnosis may still be acceptable if all other criteria are fulfilled (can occur with prior glucocorticoid treatment, elderly patients, or constitutively low baseline IgE) 1

Step 3: Obtain Supporting Evidence (Need Any Two)

Laboratory tests:

• A. fumigatus-specific IgG: Use lateral flow assays or enzyme immunoassays with population-specific cut-offs (≥27 mgA·L⁻¹ for India, ≥60 for Japan, ≥40 for UK; use manufacturer recommendations if unavailable) 1
• Blood eosinophil count: ≥500 cells·μL⁻¹ (historical values acceptable) 1

Imaging:

• Thin-section chest CT (recommended at baseline) showing: 1
  • Central bronchiectasis
  • Mucus plugging
  • High-attenuation mucus (HAM)
  • Finger-in-glove opacities
• Chest radiograph showing fleeting opacities consistent with ABPA 1

Critical Diagnostic Pearl

High-attenuation mucus on chest CT is pathognomonic for ABPA and confirms the diagnosis even if other criteria are not completely fulfilled. 1 This finding alone can establish the diagnosis in the appropriate clinical context.

Additional Diagnostic Considerations

Alternative tests when standard assays unavailable:

• Type 1 skin test is acceptable when Aspergillus-IgE testing is unavailable 1
• Elevated IgE against recombinant Aspergillus antigens (rAsp f1, f2, and f4) supports ABPA diagnosis and can serve as another diagnostic component 1

Ancillary testing:

• Sputum fungal culture: Suggested during evaluation to identify species and guide therapy, though not required for diagnosis 1
• Bronchoscopy: NOT routinely recommended 1. Reserve for:
  • Uncertain diagnosis
  • Suspected ABPM where sputum cultures are uninformative
  • Unexplained hemoptysis
  • Suspicion of concurrent tuberculous or non-tuberculous mycobacterial infection before starting glucocorticoids 1

Tests NOT recommended:

• Serum galactomannan has no role in ABPA diagnosis 1

Common Pitfalls to Avoid

1. Don't dismiss ABPA in patients without documented asthma—the disease can occur without prior asthmatic history 2, 3

2. Don't exclude ABPA based solely on total IgE <500 IU·mL⁻¹—this can occur with prior steroid use or in elderly patients; if all other criteria are met, diagnosis remains valid 1

3. Don't overlook high-attenuation mucus on CT—this single finding is diagnostic even when other criteria are incomplete 1

4. Don't confuse ABPA with ABPM—if A. fumigatus-specific IgE is <0.35 kUA·L⁻¹ but clinical suspicion remains high, consider ABPM from other fungi (requires repeated fungal cultures showing the causative organism) 1

5. Don't order unnecessary invasive testing—bronchoscopy is not routinely needed and should be reserved for specific clinical scenarios 1